Form 4: Director Duhay Granted NVNO Stock Options

enVVeno Medical Corp director Francis Duhay was granted 135,883 stock options with a $0.325 exercise price, vesting quarterly in 2026.

Summary

• Francis Duhay, a Director of enVVeno Medical Corp (NVNO), was granted 135,883 stock options.
• The options have an exercise price of $0.325 per share.
• The grant occurred on December 11, 2025, pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended.
• These options are subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2026 calendar year.
• The options expire on December 11, 2035.

Sentiment

Score: 6

Explanation: The filing reports a routine compensation event (stock option grant) to a director, which is generally a neutral to slightly positive event as it aligns interests, but does not indicate significant operational or financial news.

Positives

• The grant of stock options aligns the director's long-term interests with those of the shareholders, incentivizing performance.
• The transaction is part of an existing, approved incentive plan, indicating structured corporate governance regarding compensation.

Future Outlook

The stock options granted to the director are subject to time-based vesting throughout the 2026 calendar year, indicating a future incentive structure tied to continued service.

Management Comments

• The common stock options were issued to the Reporting Person pursuant to the Issuer's Amended and Restated 2016 Omnibus Incentive Plan, as amended.
• The award is subject to time-based vesting and will vest in equal quarterly installments on the last day of each fiscal quarter during the 2026 calendar year.

Industry Context

The grant of stock options to a director is a standard practice in the industry for executive and director compensation, aiming to align the interests of leadership with long-term shareholder value.

Comparison to Industry Standards

• This grant represents a routine compensation mechanism for directors, consistent with common practices across various industries to incentivize long-term commitment and performance.
• The use of an existing Omnibus Incentive Plan for the grant is a standard corporate governance practice, ensuring compensation is structured and approved.

Corporate Governance

Related Party Transactions

• Grant of 135,883 stock options to Francis Duhay, a Director of enVVeno Medical Corp, as part of his compensation under the company's Amended and Restated 2016 Omnibus Incentive Plan.

Stakeholder Impact

• Shareholders: Potential future dilution if options are exercised, but also increased alignment of the director's interests with long-term shareholder value and company performance.
• Director (Francis Duhay): Receives a significant equity incentive, linking personal wealth to the company's stock performance and providing motivation for continued service.

Next Steps

• The granted stock options will vest in equal quarterly installments throughout the 2026 calendar year.

Key Dates

Recommendation

This Form 4 reports a routine grant of stock options to a director as part of an existing incentive plan. It does not provide new information that would fundamentally alter the investment outlook for enVVeno Medical Corp, thus a 'hold' recommendation is appropriate as it does not warrant a change in investment thesis.

Keywords

enVVeno Medical Corp, NVNO, Stock Options, Director Compensation, Insider Transaction, Form 4, Francis Duhay, Equity Incentive Plan